ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $35,110,000 | +60.2% | 1,861,630 | 0.0% | 2.34% | +119.6% |
| Q2 2019 | $21,911,000 | -13.8% | 1,861,630 | 0.0% | 1.06% | +0.5% |
| Q1 2019 | $25,411,000 | +33.2% | 1,861,630 | 0.0% | 1.06% | +4.3% |
| Q4 2018 | $19,082,000 | -38.2% | 1,861,630 | +0.5% | 1.02% | -18.5% |
| Q3 2018 | $30,854,000 | +5.4% | 1,853,101 | 0.0% | 1.25% | +6.6% |
| Q2 2018 | $29,279,000 | +24.6% | 1,853,101 | +0.2% | 1.17% | +16.4% |
| Q1 2018 | $23,493,000 | +11.5% | 1,849,832 | +0.5% | 1.00% | +10.8% |
| Q4 2017 | $21,071,000 | +2570.6% | 1,840,246 | +2757.5% | 0.91% | +2648.5% |
| Q3 2017 | $789,000 | – | 64,400 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |